Manitoba Has a Bigger Story to Tell We can fall into the cycle of overestimating what we can accomplish in a year while underestimating what we can achieve in five to ten years. Sometimes, the greatest opportunities are “hiding” in plain sight. To make those larger, long-term goals a reality, we must embrace what we
Bioscience Association Manitoba (BAM) serves as the central connector and catalyst for the province’s bioscience sector, bringing together companies, researchers, educators, students, and government partners to strengthen an industry that is steadily growing in both scale and impact. BAM was created with an important purpose: to support the development of Manitoba’s bioscience ecosystem and help
Century Therapeutics is a Philadelphia-based, biotechnology company working to reimagine the potential of cell therapy across a number of serious diseases. The company is developing investigational cell therapies derived from induced pluripotent stem cells, or iPSCs, to potentially treat autoimmune diseases, like Type 1 diabetes (T1D), as well as cancer. THE VISION At the heart
CENTURY THERAPEUTICS – ENGINEERING AN EVOLUTION IN CELL THERAPY Read More »
Philadelphia has long been a city of innovation. For the last 25 years, Integral Molecular has helped write that story, advancing better, safer antibody drugs and developing tools that accelerate vaccine discovery. Founded and grown in Philadelphia, Integral Molecular develops and applies innovative technologies to study and target membrane proteins for therapeutics. These proteins include
Integral Molecular – Celebrating 25 Years of Innovation and Impact Read More »
DESIGNED IN PHILADELPHIA. MADE IN USA. SHIPPED WORLDWIDE. Founded in Philadelphia in 2015 by an immigrant biomedical researcher, AUM BioTech now designs the precision compounds that scientists in nearly forty countries use to study how genes function, and understand what goes wrong in disease. In 2009, Veenu Aishwarya arrived in Philadelphia from India to train
AUM BioTech – An AI-native biotech, helping scientists understand the causes of disease Read More »
In Maryland, scientific discovery rarely slows progress. Laboratories across the state generate breakthrough therapeutics, diagnostics, and medical technologies at remarkable speed. Moving those innovations beyond the lab and into the hands of patients and investors requires a different kind of expertise, grounded in market insight, capital strategy, and disciplined execution. BioHealth Innovation was created to
BioHealth Innovation – Translating Breakthroughs into Impact Read More »
Conversations about innovation happen constantly, yet execution rarely receives the same attention. Breakthrough research can capture headlines, attract investment, and signal scientific progress, yet discovery alone rarely builds industries or creates lasting economic growth. The hard work continues after the breakthrough, when ideas must leave the laboratory and prove themselves in the real world. Researchers
RICH BENDIS – FOUNDER, PRESIDENT, AND CEO, BIOHEALTH INNOVATION, INC. (BHI) Read More »
CIC builds and operates a global network of innovation campuses where startups, scale-ups, corporations and public entities connect, work, and grow. Founded in 1999, CIC manages innovation-focused workspace, laboratories, and event space across North America, Europe, and Asia. Additionally, CIC develops bespoke programming, builds and enables industry clusters, and provides world-class district consulting—all focused on
The Brock Family Center for Applied Innovation was established at Vanderbilt University Medical Center in 2023 through a $10 million gift from the Brock family, including John F. Brock III, his wife, Mary, and their three adult children – Rebecca Brock Dixon, John F. Brock IV and Major Brock. The Brock family has supported the
Aging is the single greatest risk factor for every major chronic disease — yet the global wellness and supplement market still treats human biology as if one size fits all. Consumers spend billions on generic products, vague claims and underdosed formulas — yet see little measurable impact. At the same time, aging science is advancing
LIFESEEDS – BUILDING THE NORDIC BRIDGE TO PERSONALIZED LONGEVITY Read More »
AGING IS THE NEXT FRONTIER OF INNOVATION Not because it’s a poetic idea, but because aging is biology, and biology is technology. We’ve spent decades reinventing the digital world while accepting the human body as something fixed and unchangeable. That assumption is about to collapse. I’ve spent years testing treatments most people won’t hear about
MATHIAS LOBENDAHL – FOUNDER, LIFESEEDS Read More »
In Estonia, where wood has shaped livelihoods for centuries, one company is reimagining its potential for the next industrial era. Fibenol is transforming undervalued hardwood and plywood industry residues into high-purity biomaterials that offer sustainable alternatives to fossil-based inputs. Its mission is both simple and bold: To help industries defossilize their value chains and accelerate
FIBENOL – DEFOSSILIZING THE FUTURE OF MATERIALS AND CHEMICALS Read More »
Some of the most meaningful innovations don’t begin with a grand plan. They begin when you hit a wall. A few years ago, we were developing a new therapeutic antibody. To really understand it, we had to figure out where it grabbed onto its target molecule—and what happened to that target once the antibody latched
DANIEL X JOHANSSON – CSO & CO-FOUNDER, AAX BIOTECH Read More »
In the heart of Sweden’s thriving life sciences ecosystem, a young biotechnology company is redefining how the world understands and engineers therapeutic antibodies. Founded by researchers from the prestigious Karolinska Institutet, AAX Biotech is on a mission to transform antibody-based medicine—turning scientific breakthroughs into next-generation therapies for some of the world’s most challenging diseases. Science-driven,
AAX BIOTECH – PIONEERING THE NEXT WAVE OF PRECISION ANTIBODY THERAPEUTICS Read More »
I studied molecular science because I wanted to understand how things work. I built a strong knowledge of molecular processes, but the turning point came when my mother was diagnosed with melanoma. I could explain the disease in detail, but I couldn’t change its course. That loss shifted my focus from curiosity alone to curiosity
PROF. MART USTAV – CHIEF EXECUTIVE OFFICER, ICOSAGEN GROUP Read More »
On Northern Europe’s digital frontier, Icosagen stands out in the biotechnology landscape. Based in Tartu, Estonia’s second‑largest city, it is not only the country’s largest biotech company but also one of the most agile Contract Research, Development and Manufacturing Organizations (CRDMOs) operating globally. What truly sets Icosagen apart is its identity — privately held, family‑led,
ICOSAGEN – ESTONIA’S INDEPENDENT BIOTECH PIONEER WITH GLOBAL REACH Read More »
When I was a young researcher, I believed invention was the pinnacle of achievement. To discover something new and build something no one had built before – that felt like enough. But after launching several deep tech startups, I’ve learned a powerful lesson. Invention is just the beginning. Innovation is what changes the world. The
MOHAMAD TAKWA – CEO & CO-FOUNDER, EPIGENICA Read More »
There must be more MDs and PhDs per capita in a 10-mile radius of Rockville, Maryland, than anywhere else in the country. Montgomery County is the foundation of the Biotech Corridor, a dynamic hub for life science research, innovation, and commercialization, with 13,000 private sector employees and 400 life sciences companies. Rockville is undoubtedly the
THE BIOTECH CORRIDOR – WHERE INNOVATION LEADS Read More »
Not long ago, decoding DNA was the holy grail of biology. Today, a growing number of scientists and clinicians believe that the key to the next generation of healthcare lies in understanding how our genes are controlled – epigenetics. Epigenica, a Swedish biotech company founded by Dr. Mohamad Takwa and Prof. Simon Elsässer, is turning
EPIGENICA – DEMOCRATIZING LARGE-SCALE EPIGENOMICS FOR THE AGE OF PERSONALIZED HEALTHCARE Read More »
Life Sciences Nova Scotia (LSNS) is more than just an organization; it is the cornerstone of Nova Scotia’s life sciences community, fostering growth, innovation, and collaboration across the province and Atlantic Canada. At its core, LSNS is driven by the belief that transformative ideas in biotechnology, healthcare, and pharmaceuticals can improve lives and generate lasting
LIFE SCIENCES NOVA SCOTIA – BUILDING A THRIVING COMMUNITY Read More »
As the CEO of Life Sciences Nova Scotia, I have the privilege of witnessing firsthand the creativity, resilience, and vision of the people and companies driving change in the life sciences sector. From pioneering healthcare solutions to cutting-edge biotechnology developments, the Atlantic region is making a profound impact both locally and globally. This book is
DORIS GRANT – CEO, LIFE SCIENCES NOVA SCOTIA Read More »
In a world of rapidly rising temperatures and unstable growing conditions, Potato Improver is reshaping the future of agriculture by empowering one of the world’s most essential food crops—potatoes—to thrive in heat-stressed environments. Founded with a singular mission to safeguard global food security, this Swedish biotech startup has developed a breakthrough CRISPR/Cas-based technology that enables
POTATO IMPROVER – ENGINEERING RESILIENCE IN THE AGE OF CLIMATE CHANGE Read More »
Sightera Biosciences accelerates drug discovery with an innovative approach that combines chemical structure analysis with complex patient-relevant preclinical models to design novel therapies. Due to the organization’s exclusive research collaboration with the DrugVision.AI screening platform of the University of Antwerp/UZA, it can produce exclusive datasets from patient-derived models to train its AI-driven engine, focusing on
Sightera – Complex Patient-Derived Biology Meets AI-Drug Design Read More »
TACKLING THE CHALLENGES OF WATER QUALITY MANAGEMENT: XELEMENT TECHNOLOGY LEADS THE WAY As climate change accelerates, the effects on our environment become more pronounced. Rising temperatures, erratic weather patterns, and dwindling resources create a host of problems, with water quality being acritical concern. Warmer temperatures and oxygen depletion disrupt the delicate balance of aquatic ecosystems,
XElement Technology Read More »